Pfizer
FDA Approves Updated COVID-19 Vaccines
With the Food and Drug Administration’s clearance, Pfizer and Moderna are set to begin shipping millions of doses. A third U.S. manufacturer, Novavax, expects its modified vaccine version to be available a little later. read more >
by Associated Press -
FDA Advisers Urge Targeting JN.1 Strain in Recipe for Fall’s COVID Vaccines
Moderna, Pfizer and Novavax all said they could have supplies of JN.1-specific shots ready by fall, although they didn't provide amounts. read more >
by Associated Press -
US Adds Another Option for Fall COVID Vaccination With Updated Novavax Shots
Updated vaccines from Pfizer and Moderna began rolling out last month, intended for adults and children as young as age 6 months. read more >
by Associated Press -
RSV Vaccine Recommended During Pregnancy as a Second Option to Protect Newborns
The shots should be given late in pregnancy but only during RSV season, the Centers for Disease Control and Prevention said. read more >
by Associated Press -
US Approves 1st Vaccine for RSV After Decades of Attempts
The move sets the stage for adults 60 and older to get vaccinated this fall — but first, the Centers for Disease Control and Prevention must decide if every senior really needs RSV protection or only those considered at high risk from the respiratory syncytial virus. read more >
by Associated Press -
US Proposes Once-a-Year COVID Shots for Most Americans
The FDA will ask its panel of outside vaccine experts to weigh in at a meeting Thursday. read more >
by Associated Press -
Pfizer Says COVID-19 Vaccine Will Cost $110-$130 Per Dose
Commercial pricing for adult doses could start early next year, depending on when the government phases out its program of buying and distributing the shots. read more >
by Associated Press -
FDA Clears Updated COVID Boosters for Kids as Young as 5
There's one more step before parents can bring their kids in for the new shot: The Centers for Disease Control and Prevention, which recommends how vaccines are used, must sign off. read more >
by Associated Press -
Pfizer Seeks to Expand Omicron Booster to 5- to 11-Year-Olds
FDA vaccine chief Dr. Peter Marks said last week he expected a decision on boosters for that age group soon. read more >
US Clears Updated COVID Boosters Targeting Newest Variants
The move by the Food and Drug Administration tweaks the recipe of shots made by Pfizer and rival Moderna that already have saved millions of lives. read more >
by Associated Press -
US Allows Pharmacists to Prescribe Pfizer’s COVID-19 Pill
The announcement comes as COVID-19 cases, hospitalizations and deaths are rising again, though they remain near their lowest levels since the coronavirus outbreak began in 2020. read more >
by Associated Press -
US Making COVID Antiviral Drug More Available at Test Sites
About 25,000 to 30,000 courses of Paxlovid are being prescribed each day. read more >
Joyce Lee Named New President of Cobb-Vantress
She was previously an executive in the pet health and commercial operations division of Elanco. read more >
US Expands Pfizer COVID Boosters, Opens Extra Dose to Age 16
It's not yet clear if or when teens younger than 16 might need a third Pfizer dose. read more >
by Associated Press -
Drugstores Give Shots, Then Wait for Payback
Like patients, Arkansas pharmacists have had their sleeves rolled up. read more >
by Kyle Massey -
Pfizer Asks FDA to Approve COVID-19 Booster Shots for All Adults
The drug maker is submitting early results of a booster study in 10,000 people to make its case. read more >
Pfizer: COVID-19 Vaccine Works in Kids Ages 5 to 11
Pfizer says its COVID-19 vaccine works for children ages 5 to 11 and that it will seek U.S. authorization for this age group soon — a key step toward beginning vaccinations for youngsters. read more >
by -
Biden Announces Mandate Requiring COVID-19 Vaccinations Or Weekly Testing At Large Businesses
About 80 million Americans will be affected by the rule, and employers can be fined for violations. read more >
by Associated Press -
Medical, Faith Issues Arise as Employers Require Shots
In the wake of the U.S. Food & Drug Administration’s full approval last week of Pfizer’s vaccine for COVID-19, more companies are expected to mandate that their employees be vaccinated. read more >
by Mark Friedman -
No Big Backlash for States Passing Anti-Transgender Laws
Five states including Arkansas have passed laws or implemented executive orders limiting the ability of transgender youths to play sports or receive certain medical treatment — and there’s been little tangible repercussions. read more >
by -
Sign up for Daily E-news
Sign Up
THIS WEEK’S EDITION
This Week’s Stories
View Digital Edition
